AntimicrobialAnti-Gram-Positive observation
Record detail Table 2: Ctn[15-34] retroenantio MIC against E. coli 0.16 μM
- Measure
- MIC
- Value
- 0.16 µM
- Target
- Escherichia coli
- Assay
- Not reported by source
Back to Evidence
Paper-scoped peptide mentionSequence reported
Ctn_15_34_retroenantio
PMC9495681::PEP000008
Source publication
Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties.
Biomedicines · 2022
- Sequence status
- reported
- Standardization
- Sequence ready
- Source location
- text
- Activity records
- 5
Sequence evidence
Reported molecular identity
FPITVGIVMPKKFIKKLRKK
Ctn[15-34] retroenantio sequence fpitvGivmpkkfikklrkk (Table 1)
Resolved peptide links
Experimental observations
Records linked to this mention
AntimicrobialAnti-Gram-Positive observation
Record detail Table 2: Ctn[15-34] retroenantio MIC against A. baumannii 0.39 μM
- Measure
- MIC
- Value
- 0.39 µM
- Target
- Acinetobacter baumannii
- Assay
- Not reported by source
AntimicrobialAnti-Gram-Positive observation
Record detail Table 2: Ctn[15-34] retroenantio MIC against Pseudomonas sp. 0.1 μM
- Measure
- MIC
- Value
- 0.1 µM
- Target
- Pseudomonas sp.
- Assay
- Not reported by source
AnticancerCytotoxicPositive observation
Record detail Section 3.3: versus 191 μM and 43 μM for Ctn[15-34] enantio and Ctn[15-34] retroenantio
- Measure
- other
- Value
- 43 µM
- Target
- 1BR3G
- Assay
- Not reported by source
OtherPositive observation
Record detail Section 3.5: Ctn[15-34] retroenantio, with unusually high serum stability (t1/2 = 921 min)
- Measure
- other
- Value
- t1/2 = 921 min
- Target
- Homo sapiens
- Assay
- Not reported by source
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.